CARVAJAL N ET AL: "Consequences of mutations of metal ligands in human liver arginase I.", MOLECULAR BIOLOGY OF THE CELL, vol. 13, no. Supplement, November 2002 (2002-11), page 546A, XP009157032, & 42ND ANNUAL MEETING OF THE AMERICAN SOCIETY FOR CELL BIOLOGY; SAN FRANCISCO, CA, USA; DECEMBER 14-18, 2002 ISSN: 1059-1524 (B1)

CHENG P N M ET AL: "Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma", CANCER LETTERS, NEW YORK, NY, US, vol. 224, no. 1, 16 June 2005 (2005-06-16) , pages 67-80, XP004904542, ISSN: 0304-3835 (B1)

DAVID E. ASH ET AL.: 'Structure and Function of Arginases.' THE JOURNAL OF NUTRITION vol. 134, 2004, pages 2760S - 2764S, XP008146967 (B1)

EP-A1- 1 803 465 (B1)

WO-A2-03/063780 (B1)

REHNER G ET AL: "EFFECT OF MANGANESE COBALT AND NICKEL ON THE ACTIVITY OF LIVER ARGINASE IN-VITRO AND IN-VIVO", MEDIZIN UND ERNAEHRUNG, vol. 11, no. 2, 1970, pages 32-35, XP009158520, (B1)

Stone E. et al.: "Engineering Human Arginase I as a Novel Cancer Therapeutic Agent", , 6 September 2008 (2008-09-06), XP002675137, Retrieved from the Internet: URL:http://aiche.confex.com/aiche/09icbe/p reliminaryprogram/abstract_143378.htm [retrieved on 2012-02-29] (B1)

US-A1- 2002 119 554 (B1)

WO-A1-2004/001048 (B1)

GUADALUPE SABIO ET AL.: 'Glu-256 is a main structural determinant for oligomerisation of human arginase I.' FEBS LETTERS vol. 501, 2001, pages 161 - 165, XP004274902 (B1)